We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.83B
AUM Growth
+$1B
Cap. Flow
+$1.04B
Cap. Flow %
13.23%
Top 10 Hldgs %
18.07%
Holding
1,199
New
91
Increased
872
Reduced
184
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Financials 13.75%
3 Healthcare 12.59%
4 Consumer Discretionary 10.27%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSHD icon
501
Goosehead Insurance
GSHD
$2.32B
$2.18M 0.03%
38,016
+10,464
+38% +$628K
FDS icon
502
Factset
FDS
$10.2B
$2.18M 0.03%
5,344
+573
+12% +$243K
EXPE icon
503
Expedia Group
EXPE
$37.3B
$2.18M 0.03%
17,281
+4,244
+33% +$523K
SSNC icon
504
SS&C Technologies
SSNC
$18.6B
$2.17M 0.03%
34,691
-474
-1% -$29.4K
MUSA icon
505
Murphy USA
MUSA
$9.61B
$2.17M 0.03%
4,621
+455
+11% +$198K
LBRDK icon
506
Liberty Broadband Class C
LBRDK
$5.15B
$2.17M 0.03%
39,569
+13,320
+51% +$688K
P
507
Everpure Inc
P
$29.9B
$2.14M 0.03%
+33,342
New +$1.93M
CPT icon
508
Camden Property Trust
CPT
$11.3B
$2.12M 0.03%
19,427
-150
-0.8% -$15.5K
CHD icon
509
Church & Dwight Co
CHD
$24.5B
$2.11M 0.03%
20,336
-7,057
-26% -$747K
FELE icon
510
Franklin Electric
FELE
$4.84B
$2.1M 0.03%
21,776
+2,037
+10% +$203K
NBIX icon
511
Neurocrine Biosciences
NBIX
$16.6B
$2.09M 0.03%
15,146
+1,725
+13% +$237K
IRM icon
512
Iron Mountain
IRM
$36.1B
$2.08M 0.03%
23,246
-788
-3% -$63.8K
HSY icon
513
Hershey
HSY
$36.6B
$2.08M 0.03%
11,320
+201
+2% +$38.9K
QLYS icon
514
Qualys
QLYS
$6.35B
$2.08M 0.03%
14,587
+802
+6% +$122K
YUM icon
515
Yum! Brands
YUM
$41.1B
$2.06M 0.03%
15,564
-328
-2% -$45.1K
AVTR icon
516
Avantor
AVTR
$9.19B
$2.03M 0.03%
95,830
-858
-0.9% -$20.7K
AMP icon
517
Ameriprise Financial
AMP
$48.8B
$2.03M 0.03%
4,755
+831
+21% +$355K
USPH icon
518
US Physical Therapy
USPH
$1.22B
$2.03M 0.03%
21,974
+3,536
+19% +$358K
EW icon
519
Edwards Lifesciences
EW
$51.7B
$2.03M 0.03%
21,983
+615
+3% +$54.5K
BBWI icon
520
Bath & Body Works
BBWI
$4.1B
$2.03M 0.03%
51,985
+15,243
+41% +$700K
OZK icon
521
Bank OZK
OZK
$5.61B
$2.01M 0.03%
49,145
+15,936
+48% +$693K
DY icon
522
Dycom Industries
DY
$12.3B
$2M 0.03%
11,827
-1,937
-14% -$302K
APP icon
523
Applovin
APP
$116B
$1.99M 0.03%
23,966
+12,248
+105% +$950K
TDG icon
524
TransDigm Group
TDG
$67.7B
$1.98M 0.03%
1,553
+232
+18% +$297K
TNDM icon
525
Tandem Diabetes Care
TNDM
$1.56B
$1.98M 0.03%
49,193
+8,813
+22% +$368K

Similar funds

Oppenheimer Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Oppenheimer Asset Management held 1,199 positions worth $7.83B, up 15% from $6.83B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer Asset Management deployed $1.04B of net new capital in Q2 2024, opening 91 new positions and adding to 872 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Growth ETF: 199,301 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $20.9M trimmed.

  • Oppenheimer Asset Management's largest Q2 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 199,301 shares worth $25.6M.
  • Oppenheimer Asset Management added most to Microsoft in Q2 2024, an estimated $37.8M increase.
  • Oppenheimer Asset Management's biggest Q2 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $20.9M.
  • Oppenheimer Asset Management fully exited Oshkosh in Q2 2024, selling an estimated $5.61M.
  • Oppenheimer Asset Management's ten largest holdings make up 18% of its $7.83B portfolio in Q2 2024.
  • Oppenheimer Asset Management opened 91 new positions and closed 50 in Q2 2024.
  • Oppenheimer Asset Management's portfolio value rose 15% quarter-over-quarter to $7.83B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.